213 related articles for article (PubMed ID: 11684313)
1. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).
Yamaguchi K; Honda M; Ikigai H; Hara Y; Shimamura T
Antiviral Res; 2002 Jan; 53(1):19-34. PubMed ID: 11684313
[TBL] [Abstract][Full Text] [Related]
2. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
3. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent.
Fassina G; Buffa A; Benelli R; Varnier OE; Noonan DM; Albini A
AIDS; 2002 Apr; 16(6):939-41. PubMed ID: 11919502
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells.
Nakamuta M; Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Kobayashi N; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):677-81. PubMed ID: 16142404
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate inhibits the HIV reverse transcription step.
Li S; Hattori T; Kodama EN
Antivir Chem Chemother; 2011 Jul; 21(6):239-43. PubMed ID: 21730371
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenovirus infection and adenain by green tea catechins.
Weber JM; Ruzindana-Umunyana A; Imbeault L; Sircar S
Antiviral Res; 2003 Apr; 58(2):167-73. PubMed ID: 12742577
[TBL] [Abstract][Full Text] [Related]
7. [The inhibitory effects of catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and DNA polymerases].
Tao P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Oct; 14(5):334-8. PubMed ID: 1284389
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.
de Oliveira A; Adams SD; Lee LH; Murray SR; Hsu SD; Hammond JR; Dickinson D; Chen P; Chu TC
Food Chem Toxicol; 2013 Feb; 52():207-15. PubMed ID: 23182741
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate exhibits antiviral effects against the duck Tembusu virus via blocking virus entry and upregulating type I interferons.
Zhu Y; Gu X; Zhang M; Lv X; Zhang C; Li J; Hu Z; Wu Q; Zhang R; Wei J; Huang R; Wang B; Wang Q; Wang G
Poult Sci; 2021 Apr; 100(4):100989. PubMed ID: 33647721
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
Kim M; Kim SY; Lee HW; Shin JS; Kim P; Jung YS; Jeong HS; Hyun JK; Lee CK
Antiviral Res; 2013 Nov; 100(2):460-72. PubMed ID: 23954192
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.
Nance CL; Siwak EB; Shearer WT
J Allergy Clin Immunol; 2009 Feb; 123(2):459-65. PubMed ID: 19203663
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
17. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate inhibits TF and TNF-α expression induced by the anti-β2GPI/β2GPI complex in human THP-1 cells.
Wang T; Zhou H; Xie H; Mu Y; Xu Y; Liu J; Zhang X
Int J Mol Med; 2014 Apr; 33(4):994-1002. PubMed ID: 24481129
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
20. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
